# Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

> **NCT00005856** · PHASE1,PHASE2 · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 59 (actual)

## Conditions studied

- Adult Giant Cell Glioblastoma
- Adult Glioblastoma
- Adult Gliosarcoma

## Interventions

- **DRUG:** oxaliplatin
- **OTHER:** pharmacological study

## Key facts

- **NCT ID:** NCT00005856
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-12
- **Primary completion:** 2007-01
- **Final completion:** —
- **Target enrollment:** 59 (ACTUAL)
- **Why stopped:** Administratively complete.
- **Last updated:** 2013-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005856, "Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00005856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*